Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00258
|
|||||
| Drug Name |
Furosemide
|
|||||
| Synonyms |
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid; 4-chloro-2-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid; Aisemide; Aisemide (TN); Aldalix; Aldic; Aluzine; Anfuramaide; Apo-Frusemide; Apo-Furosemide; Apo-Furosemide (TN); Aquarid; Aquasin; Arasemide; Beronald; Beronald (TN); Bioretic; Cetasix; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure [German]; Depix; Desal; Desdemin; Desdemin (TN); Dirine; Disal; Discoid; Discoid (TN); Disemide; Diumide-K; Diural; Diural (TN); Diurapid; Diurapid (TN); Diurin; Diurolasa; Diusemide; Diusil; Diuzol; Dranex; Dryptal; Dryptal (TN); Durafurid; Durafurid (TN); Edemid; Edenol; Eliur; Endural; Errolon; Errolon (TN); Eutensin; Eutensin (TN); F0182; F4381_SIGMA; FUN; FUROSEMIDE USP; Farsix; Fluidrol; Fluss; Franyl; Frudix (TN); Frumex; Frumide; Frusedan; Frusema; Frusemid; Frusemide; Frusemin; Frusenex; Frusetic; Frusetic (TN); Frusid; Frusid (TN); Fu sid; Fulsix; Fulsix (TN); Fuluvamide; Fuluvamide (TN); Fuluvamine; Fulvamide; Furanthril; Furanthryl; Furantral; Furantril; Furanturil; Furesis; Furesis (TN); Furetic; Furex; Furfan; Furix; Furix (TN); Furmid; Furo-Basan; Furo-Puren (TN); Furo-puren; Furobeta; Furocot; Furodiurol; Furodrix; Furomen; Furomex; Furomide M.D; Furomide M.D.; Furorese; Furosan; Furose; Furosedon; Furosedon (TN); Furosemid; Furosemida; Furosemida [INN-Spanish]; Furosemide (JP15/USP/INN); Furosemide (mita); Furosemide Monohydrochloride; Furosemide Monosodium Salt; Furosemide [USAN:INN:JAN]; Furosemidu; Furosemidu [Polish]; Furosemidum; Furosemidum [INN-Latin]; Furosemix; Furoside; Furosifar; Furosix; Furoter; Furovite; Fursemid; Fursemida; Fursemide; Fursol; Fusid; Fusid (TN); Golan; Hissuflux; Hoe-058A; Hydrex; Hydro; Hydro-rapid; Hydro-rapid(TN); Hydroled; Impugan; Impugan (TN); Jenafusid; Katlex; Katlex (TN); Kofuzon; Kolkin; Kutrix; LB 502; LB-502; Lasemid; Lasex; Lasiletten; Lasilix; Lasilix (TN); Lasix; Lasix (TN); Lasix Retard; Lasix Special; Lasix, Frusemide, Furosemide; Laxur; Lazix; Less Diur; Liside; Lodix (TN); Logirene; Lowpston; Lowpston (TN); Lowpstron; Luscek; Macasirool; Macasirool (TN); Marsemide; Mirfat; Mirfat (TN); Mita; Moilarorin;Myrosemide; Nadis; Nelsix; Neo-renal; Nicorol (TN); Novosemide; Odemase; Odemase (TN); Odemex; Oedemex; Oedemex (TN); Polysquall A; Prefemin; Profemin; Profemin (TN); Promedes; Promide; Protargen; Puresis; Radisemide; Radonna; Radouna; Retep; Rosemide; Rosemide (TN); Rosis; Rusyde; Rusyde (TN); Sal diureticum; Salinex; Salix; Salix (TN); Salix (brand of furosemide); Salurex; Salurid; Seguril; Selectofur; Sigasalur; Spirofur; Synephron; Transit; Trofurit; Trofurit (TN); Uremide; Uresix; Urex; Urex (TN); Urex-M; Urian; Uridon; Uritol; Urosemide; Vesix; Yidoli; Zafimida
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Edema associated with congestive heart failure [ICD11: BD10] | Approved | [1] | |||
| Therapeutic Class |
Diuretics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C12H11ClN2O5S
|
|||||
| Canonical SMILES |
C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
|
|||||
| InChI |
InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)
|
|||||
| InChIKey |
ZZUFCTLCJUWOSV-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 54-31-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 330.74 | Topological Polar Surface Area | 131 | ||
| Heavy Atom Count | 21 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321703
, 11112125
, 11335750
, 11360989
, 11363994
, 11366556
, 11369118
, 11371374
, 11374398
, 11377280
, 11461961
, 11466369
, 11467489
, 11484865
, 11486058
, 11488821
, 11490253
, 11492375
, 11494914
, 11531975
, 11534249
, 12014152
, 140841
, 14875224
, 17389872
, 22391430
, 24277714
, 26611753
, 26680261
, 26747275
, 26747276
, 26752834
, 26752835
, 29214787
, 29222574
, 46487913
, 46506779
, 47193739
, 47216755
, 47440227
, 47515298
, 47810733
, 47885389
, 48035085
, 5651429
, 597353
, 7847397
, 8149353
, 8152188
, 9229
|
|||||
| ChEBI ID |
ChEBI:47426
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [2] | |
| OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [2] | ||
| PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [3] | ||
| References | ||||||
| 1 | Furosemide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9. | |||||
| 3 | Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells. Arch Pharm Res. 2007 Apr;30(4):507-18. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.